Expectations of Serious Adverse Events at the End of Life of Patients With Acute Myeloid Leukemia Who Receive Salvage Therapy
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.03.021
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2013
Authors
Publisher
Elsevier BV